Itraconazole IR 40% Pellets
Itraconazole IR (WW) Triazole pellets for pharmaceutical formulation. High quality antifungal suitable for various dosage forms.
Product overview
Itraconazole IR 40% WW Pellets – Immediate-Release Triazole Antifungal Pellets for 40% WW Formulation Programs. Rraynex Itraconazole IR WW Pellets provide a distinct 40% immediate-release triazole variant differentiated from the base Itraconazole pellet platform. The system is engineered for consistentMultiparticulate processing and capsule filling at this defined drug load. Overview: The 40% WW immediate-release variant addresses antifungal formulations requiring a specific triazole load and IR behavior. Rraynex controls active distribution, particle morphology and residual-solvent parameters to support reproducible manufacturing. Technical specifications are available upon request. Key Features & Benefits: • Distinct 40% immediate-release triazole variant. • Controlled active distribution and pellet morphology. • Suitable for capsule filling and multiparticulate dosage forms. • Technical support for formulation development and commercial supply. SEO Content: Rraynex manufactures Itraconazole IR 40% Pellets, Itraconazole IR Pellets 40%, Itraconazole 40% Pellets, Itraconazole IR Triazole Pellets, Itraconazole 40% Pellet Manufacturer, Triazole Antifungal Pellets, Immediate Release Pellets, Antifungal Pharmaceutical Pellets, Capsule Filling Pellets and Bulk Itraconazole Pellets.
Technical & formulation advantages
- Controlled pelletization and coating for reproducible dissolution and downstream handling.
- Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
- Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
- Technical support for formulation development, scale-up and regulatory documentation.
Technical specifications are available upon request.
Applications
- Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
- Pharmaceutical formulation and commercial manufacturing for Antifungal therapies.
- CDMO and contract manufacturing programs requiring bulk itraconazole ir 40% pellets.
Bulk pharmaceutical supply & commercial manufacture
Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Itraconazole IR 40% Pellets. Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.
Contact Rraynex for bulk pellet supply • View manufacturing capabilities
Bulk pharmaceutical supply & product enquiries
Looking to source Itraconazole IR 40% Pellets in bulk? Rraynex supports pharmaceutical companies seeking Itraconazole IR 40% Pellets for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.
- product specifications
- available strengths
- technical documentation
- samples where applicable
- commercial quotations
- bulk supply information
B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.
Related capabilities
Related products
Technical specifications
- Grade
- IP / BP / USP / EP
- Type
- Pellets
- Category
- Antifungal
- Pack size
- 25/50 kg
- Available strengths
- 40.00%
- Certifications
- WHO-GMP, ISO 9001, ISO 14001
Only use specification terms supported by existing product data. Additional technical documentation is available upon request.